Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment

ClinicalTrials.gov ID: NCT02827708

Public ClinicalTrials.gov record NCT02827708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment.

Study identification

NCT ID
NCT02827708
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
324 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2016
Primary completion
Apr 9, 2018
Completion
May 14, 2018
Last update posted
Feb 16, 2020

2016 – 2018

United States locations

U.S. sites
60
U.S. states
23
U.S. cities
55
Facility City State ZIP Site status
Novo Nordisk Investigational Site Tuscumbia Alabama 35674
Novo Nordisk Investigational Site Bermuda Dunes California 92203
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Costa Mesa California 92627
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site La Jolla California 92161-0002
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Danbury Connecticut 06810
Novo Nordisk Investigational Site Norwalk Connecticut 06851
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Clearwater Florida 33756
Novo Nordisk Investigational Site Cooper City Florida 33024
Novo Nordisk Investigational Site Jacksonville Florida 32258
Novo Nordisk Investigational Site Miami Lakes Florida 33014
Novo Nordisk Investigational Site New Port Richey Florida 34652
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site Palm Harbor Florida 34684
Novo Nordisk Investigational Site Pembroke Pines Florida 33027
Novo Nordisk Investigational Site Atlanta Georgia 30339
Novo Nordisk Investigational Site Atlanta Georgia 30342
Novo Nordisk Investigational Site Lawrenceville Georgia 30046
Novo Nordisk Investigational Site Marietta Georgia 30060
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Gurnee Illinois 60031
Novo Nordisk Investigational Site Avon Indiana 46123
Novo Nordisk Investigational Site Franklin Indiana 46131
Novo Nordisk Investigational Site Slidell Louisiana 70461-4231
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Baltimore Maryland 21287
Novo Nordisk Investigational Site Buckley Michigan 49620
Novo Nordisk Investigational Site Omaha Nebraska 68198
Novo Nordisk Investigational Site Lebanon New Hampshire 03756
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Teaneck New Jersey 07666
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site New Hyde Park New York 11042
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Asheboro North Carolina 27203
Novo Nordisk Investigational Site Whiteville North Carolina 28472
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Fargo North Dakota 58103
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Delaware Ohio 43015
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Norman Oklahoma 73069
Novo Nordisk Investigational Site Murrells Inlet South Carolina 29576
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Houston Texas 77058
Novo Nordisk Investigational Site Houston Texas 77061
Novo Nordisk Investigational Site Houston Texas 77081
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site San Antonio Texas 78212
Novo Nordisk Investigational Site Richmond Virginia 23219
Novo Nordisk Investigational Site Winchester Virginia 22601-3834
Novo Nordisk Investigational Site Winchester Virginia 22601
Novo Nordisk Investigational Site Olympia Washington 98502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02827708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02827708 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →